Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Net Income (2016 - 2025)

Historic Net Income for Abeona Therapeutics (ABEO) over the last 15 years, with Q3 2025 value amounting to -$35.6 million.

  • Abeona Therapeutics' Net Income fell 1747.33% to -$35.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.8 million, marking a year-over-year increase of 16761.36%. This contributed to the annual value of -$68.4 million for FY2024, which is 4387.95% down from last year.
  • As of Q3 2025, Abeona Therapeutics' Net Income stood at -$35.6 million, which was down 1747.33% from $108.8 million recorded in Q2 2025.
  • Abeona Therapeutics' 5-year Net Income high stood at $108.8 million for Q2 2025, and its period low was -$46.7 million during Q4 2021.
  • In the last 5 years, Abeona Therapeutics' Net Income had a median value of -$15.2 million in 2021 and averaged -$10.3 million.
  • Its Net Income has fluctuated over the past 5 years, first tumbled by 19485.09% in 2021, then skyrocketed by 136952.47% in 2025.
  • Abeona Therapeutics' Net Income (Quarter) stood at -$46.7 million in 2021, then soared by 71.9% to -$13.1 million in 2022, then fell by 1.56% to -$13.3 million in 2023, then crashed by 33.31% to -$17.8 million in 2024, then crashed by 100.28% to -$35.6 million in 2025.
  • Its Net Income was -$35.6 million in Q3 2025, compared to $108.8 million in Q2 2025 and -$20.7 million in Q1 2025.